Global Retirement Partners’s VanEck Pharmaceutical ETF PPH Stock Holding History

Global Retirement Partners’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$19.9K	Buy	193 +18	+10%	+$1.75K	﹤0.01%	2871
2025 Q3	$15.9K	Sell	175 -95	-35%	-$8.32K	﹤0.01%	2500
2025 Q2	$23.8K	Buy	+270	New	+$23.4K	﹤0.01%	2200
2024 Q4	$25.3K	Sell	293 -167	-36%	-$15.1K	﹤0.01%	1964
2024 Q3	$43.7K	Buy	460 +74	+19%	+$7.03K	﹤0.01%	1618
2024 Q2	$35.3K	Sell	386 -5	-1%	-$446	﹤0.01%	1713
2024 Q1	$35.4K	Buy	391 +375	+2,344%	+$32.8K	﹤0.01%	1557
2023 Q4	$1.34K	Buy	16 +1	+7%	+$78	﹤0.01%	2812
2023 Q3	$1.2K	Sell	15 -60	-80%	-$4.84K	﹤0.01%	2716
2023 Q2	$5.91K	Hold	75	–	–	﹤0.01%	2143
2023 Q1	$5.95K	Buy	+75	New	+$5.78K	﹤0.01%	2108

Other funds holding PPH

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BCIM

British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Global Retirement Partners's PPH Position: Q4 2025 in Review

Global Retirement Partners increased its VanEck Pharmaceutical ETF (PPH) stake by 10% in Q4 2025, buying an estimated $1.75K and bringing the position to 193 shares worth $19.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2871.

Global Retirement Partners first reported a position in PPH in Q1 2023 and has held it in 11 quarters since. The position peaked at $43.7K in Q3 2024. 146 funds tracked by Wall St. Rank hold PPH as of Q4 2025.

Global Retirement Partners held 193 shares of VanEck Pharmaceutical ETF worth $19.9K as of Q4 2025.
Global Retirement Partners bought 18 VanEck Pharmaceutical ETF shares in Q4 2025, an estimated $1.75K.
VanEck Pharmaceutical ETF made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #2871 holding.
Global Retirement Partners first reported a position in VanEck Pharmaceutical ETF in Q1 2023 and has held it in 11 quarters since.
Global Retirement Partners's VanEck Pharmaceutical ETF position peaked at $43.7K in Q3 2024.
146 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.